Related Experiment Videos
Abnormal proteolysis in sick newborns
Insights
Newborn infants often show coagulation and fibrinolytic system defects, particularly those with severe illness. "Multiple defects" were linked to illness severity and outcomes, not specific neonatal disorders.
Area of Science:
- Neonatal Medicine
- Hematology
- Pediatrics
Background:
- Neonatal hemostasis is complex and differs significantly from adult hemostasis.
- Infants are prone to bleeding and thrombotic disorders due to immature coagulation and fibrinolytic systems.
Purpose of the Study:
- To investigate defects in the coagulation and fibrinolytic systems in newborn infants on their first day of life.
- To determine if specific patterns of hemostatic abnormalities are associated with Idiopathic Respiratory Distress Syndrome (IRDS) or mixed neonatal disorders.
- To explore the relationship between illness severity, clinical course, and the presence of multiple hemostatic defects.
Main Methods:
- Studied 87 newborn infants within the first 24 hours of life.
- Assessed coagulation and fibrinolytic system parameters, including Factor V, fibrinogen, and fibrin/fibrinogen degradation products (FDP).
- Categorized infants into groups based on diagnosis (IRDS vs. mixed neonatal disorders) and clinical outcomes (survival vs. death).
Main Results:
- Factor V, fibrinogen, and FDP abnormalities were most frequent among the studied parameters.
- The presence of "multiple defects" in hemostasis was significantly associated with illness severity and mortality (85% of deceased infants had multiple defects vs. 28% of survivors).
- No significant difference in the pattern of hemostatic abnormalities was observed between infants with IRDS and those with mixed neonatal disorders.
Conclusions:
- Neonatal hemostatic defects are common and can be severe, particularly in critically ill infants.
- Multiple hemostatic defects are linked to poor prognosis in newborns.
- Potential mechanisms for these defects include impaired synthesis (e.g., vitamin K deficiency, liver damage) and abnormal proteolytic activity leading to dysregulated coagulation and/or fibrinolysis.
Abstract:
87 newborn infants were studied on their first day of life for defects in the coagulation and fibrinolytic systems. The infants were divided into two diagnostic groups, one with IRDS, the other with mixed neonatal disorders. Factor V, fibrinogen and fibrin/fibrinogen degradation products (FDP) were abnormal more often than any of the other factors examined. The presence or absence of "multiple defects" appeared to depend on the severity of the illness and its ultimate course. Thus 28% of the surviving infants or 85% of those who died had "multiple defects". The pattern of abnormalities did not differ between the infants with IRDS and those with mixed disorders. The "multiple defects" are ascribed to the following mechanisms: (1) impaired synthesis due to vitamin K deficiency and/or liver damage, (2) abnormal proteolytic activity stimulated by tissue damage and causing (a) an activation of the coagulation process (b) activation of the fibrinolytic system, or (c) of both the coagulation and the fibrinolytic systems. Differentiation between these pathways to defective haemostasis are important when deciding upon therapeutic measures in addition to the basic treatment.